Overall Technical outlook

Price Summary

On 2026-06-03, Gland Pharma Limited's shares started at 2277.0, peaked at 2305.9, bottomed out at 2222.0, and ended -1.96% down at 2232.3, with 255543 shares traded.
The stock's highest value over the last 52 weeks is 2334.0, and the lowest value is 1596.8.

Technicals

Support and Resistance: At 2232.3, the price for GLAND is supported at 1895.7 and resisted at 2292.4. This indicates a trading range where 1895.7 serves as a support level, potentially preventing further decline, while 2292.4 could limit upward movement.
GLAND supportResistance 92eb77
Support/Resistance for GLAND


Aroon: The AROON is showing a neutral stance, not indicating a clear upward or downward trend for Gland Pharma Limited. This suggests a period of market balance, where neither side is showing dominance.
GLAND aroon 92eb77
Aroon chart for Gland Pharma Limited


Bol. Bands: The current reading of the BOLL BANDS indicator suggests a neutral stance, with no clear signals indicating an upward or downward direction. This lack of directional bias suggests the market may be in a period of consolidation or uncertainty.
GLAND bbands 92eb77
Bolinger Bands chart for Gland Pharma Limited


Parabolic SAR: The PSAR for GLAND remains bearish, establishing a key resistance level that could hinder upward movement. This ongoing bearish outlook suggests that the market may face challenges in breaking higher, with the resistance level acting as a barrier to potential gains.
GLAND psar 92eb77
Parabolic Stop and Reverse chart for Gland Pharma Limited


Stochastic: The current state of the STOCHASTIC is neutral for GLAND, providing no clear indication of a trend in either direction. This suggests that the market may be lacking momentum, making it difficult to predict future movements.
GLAND stoch 92eb77
Stochastic chart for Gland Pharma Limited


Tripple Moving Agerage: The alignment of the 20, 50, and 100 moving averages points to a bearish trend, but the slopes of the 20 and 50 SMAs are starting to waver. This weakening of the bearish momentum could indicate that the market is approaching a turning point, with the possibility of a bullish reversal on the horizon. Investors should be alert for signs of a trend change as the current downtrend may be losing steam.
GLAND trippleSMA 92eb77
Tripple SMA chart for Gland Pharma Limited


When evaluating a company's technical indicators like price trends and trading volume, it's important to also assess its fundamentals. Key factors include the company's profitability, growth rate, and financial stability. Furthermore, considering the industry within which the company operates provides additional context, as factors like competition and market demand can affect performance. By combining this analysis, you can make more informed judgments about the company's future prospects.